Fang-Fang Duan

Jun 25, 2024 | bmccancer.biomedcentral.com | Xin Hua |Fei Xu |Wei Shi |Xin Huang |Fang-Fang Duan |Si-Fen Wang | +7 more

Participants in this research included 858 patients with NPC who had platinum-based CCRT at the Sun Yat-sen University Cancer Center from January 2010 to December 2014. Table 1 provides an overview of the clinicopathological features at baseline. Notably, 638 (74.4%) of the total patients were male, while 220 (25.6%) were female, with 64 years being the median age (range: 18–84 years). There were 436 (50.8%) patients > 45 years old and 422 (49.2%) patients under the age of 45.

Oct 7, 2023 | mdpi.com | Xin Hua |Lu Cao |Meng-Di Wang |Fang-Fang Duan

1. IntroductionGlobally, breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer death among women [1]. Approximately 2.3 million new cases of breast cancer are diagnosed each year, and 685,000 people die from it [1]. In the treatment of breast cancer, neoadjuvant chemotherapy (NAC) has brought new hope with breakthroughs in effective treatment.